MedTrace Logo

the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis

NCT05626166 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-04-12

No results posted yet for this study

Summary

This is a randomized, controlled study evaluating diosmin tablets administered daily for 3 months. The purpose of the study is to evaluate the efficacy and safety of diosmin in the treatment of mild to moderately active ulcerative colitis. Disease activity will be measured using modified truelove and witt's classification.

Conditions

Interventions

DRUG

Placebo

placebo tablets twice daily

DRUG

Diosmin

diosmin 600 mg twice daily

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • tarek M mostafa, professor · Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-15
Primary Completion
2023-11-30
Completion
2024-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05626166 on ClinicalTrials.gov